Medical Digest & Congress Report

Dr. Evan A Stein shares his insights on the emerging opportunities for managing cardiometabolic syndrome at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:long-term-efficacy-and-safety-lerodalcibep-open-label-72-week-extension-study-subjects-previously-inclisiran-or-lerodalcibep-liberate-vi-trial

Professor Eugene Yang shares his insights on the 2025 AHA Blood Pressure Guideline & CKD Management at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:2025-aha-blood-pressure-guideline-ckd-management-key-insights-and-global-perspectives-report-aha-2025

Professor Samia Mora explains her opinion on lipid lowering therapies and lipid risk factors at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:lipid-lowering-therapies-and-lipid-risk-factors

Professor Debabrata Mukherjee shares his insights on the Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:new-2025-guideline-acute-coronary-syndromes

Professor Robert O. Bonow shares his insights on aortic regurgitation, imaging, interventions, and the future of treatment at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:aortic-regurgitation-new-frontier-imaging-interventions-and-future-treatment

Professor Cécile Badoual shares her thoughts on the immuno-oncology biomarkers in locally advanced HNSCC and explains the lessons from the KeyNote-689 trial after the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:immuno-oncology-biomarkers-locally-advanced-hnscc-lessons-keynote-689-trial

Professor Julien Taieb shares his thoughts on the novelties of the treatment of colon cancer at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-colon-cancer-esmo-2025

Professor Jalid Sehouli explains how to break the wall of platinum-resistance in ovarian cancer at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:how-proc-breaking-wall-platinum-resistance-ovarian-cancer

Professor Thomas B. Powles discuss the results from IMvigor011, a phase 3 trial of ctDNA-guided adjuvant atezolizumab versus placebo in muscle invasive bladder cancer were presented at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:imvigor011-phase-3-trial-ctdna-guided-adjuvant-atezolizumab-versus-placebo-mibc

Professor Sibylle Loibl shares her thoughts on the additional analyses of DESTINY-Breast09 were presented at the ESMO Congress 2025. Key subgroup analysis of DESTINY-Breast09 confirms efficacy of trastuzumab deruxtecan plus pertuzumab for treating HER2+ advanced or metastatic breast cancer across groups. Video: https://medicaldigest.org/scientific-contents/interview:t-dxd-effective-treating-her2-a...

Professor Emanuela Romano explains what's new in ESMO guidelines on hepatocellular carcinoma, cutaneous melanoma, Hodgkin Lymphomas and early stage and locally advanced non-small cell lung cancers at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:whats-new-esmo-guidelines

Professor Jeanne Tie shares her thoughts on the DYNAMIC-III trial results were presented at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:dynamic-iii-trial-results-ctdna-blood-test-powerful-tool-guide-treatment-choices-people-advanced-colon-cancer

Professor Dirk Schadendorf shares his thoughts on the overcoming therapeutic challenges in high-risk cutaneous squamous cell carcinoma at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:overcoming-therapeutic-challenges-high-risk-cutaneous-squamous-cell-carcinoma-multidisciplinary-approach

Professor Christof Vulsteke shares her thoughts on the data from the phase 3 KEYNOTE-905 trial were presented at the ESMO Congress 2025. A treatment regimen consisting of neoadjuvant enfortumab vedotin-ejfv plus pembrolizumab, radical cystectomy plus pelvic lymph node dissection, and adjuvant EV plus pembrolizumab yielded significant improvements in multiple outcomes in patients with muscle-invasi...

Professor Maria De Santis shares her thoughts on the final analysis of the phase 3, open-Label, randomized POTOMAC trial were presented at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:durvalumab-combination-bcg-bcg-naive-high-risk-nmibc-final-analysis-phase-3-open-label-randomized-potomac-trial

Professor Hisham M. Mehanna shares his thoughts on the treatment landscape in resectable LA HNSCC at ESMO 2005 at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:treatment-landscape-resectable-la-hnscc

Professor Danny Rischin shares his thoughts on the analysis of second primary cutaneous squamous cell carcinoma tumors reported during the C-POST trial were presented at the ESMO Congress 2025. The study is a randomized phase III study of adjuvant cemiplimab vs placebo for high-risk CSCC. Video: https://medicaldigest.org/scientific-contents/interview:analysis-second-primary-cutaneous-squamous-cell...

Professor Irene Burger explains how to unlock the potential of radioligand therapy for advanced prostate cancer at the ESMO Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:unlocking-potential-radioligand-therapy-advanced-prostate-cancer

Prof. Andriani Charpidou co-chaired a very interesting session at this year's ERS congress on lung cancer screening updates. Video: https://medicaldigest.org/scientific-contents/interview:thoracic-oncology-lung-cancer-screening-updates-switch-gears-move-forward

Prof. Job F.M. van Boven co-chaired a very interesting session at this year's ERS congress on advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines. Video: https://medicaldigest.org/scientific-contents/interview:advancing-lung-cancer-care-real-world-evidence-artificial-intelligence-and-computerised-clinical-guidelines

Dr. Nazia Chaudhuri co-chaired a very interesting session at this year's ERS congress on horizon scanning in the treatment of interstitial lung diseases. Video: https://medicaldigest.org/scientific-contents/interview:horizon-scanning-treatment-interstitial-lung-diseases

Prof. Andrew Bush share his thoughts on the generational challenge in lung health amidst the growing number of novel tobacco products at ERS Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:addressing-generational-challenge-lung-health-amidst-growing-number-novel-tobacco-products

Prof. Michael Kreuter co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic interventions for the management of interstitial lung diseases. Video: https://medicaldigest.org/scientific-contents/interview:emerging-therapeutic-interventions-management-interstitial-lung-diseases

Prof. Catharina Moor co-chaired a very interesting session at this year's ERS congress on the current controversies in interstitial lung diseases. Video: https://medicaldigest.org/scientific-contents/interview:current-controversies-interstitial-lung-diseases

Prof. Ildiko Horvath share her thoughts on prevention in the joint action on respiratory disease at ERS Congress 2025. Video: https://medicaldigest.org/scientific-contents/interview:prevention-action-prevention-joint-action-respiratory-diseaseers